Skip to main content
. 2021 Nov 4;34(4):566–575. doi: 10.1093/icvts/ivab291

Table 2:

Treatment and outcome characteristics of patients treated with TT

TT (N = 61)
Resection type (no. of patients, %)
 Lobectomy 52 (85)
 Pneumonectomy 6 (9.8)
 Wedge resection 2 (3.3)
 Mediastinal lymph node debulking 1 (1.6)
Pathological complete response
(tumour and lymph nodes, no. of patients, %)
 Yes 18 (30)
 No 41 (67)
 Unknown 2 (3.2)
Resection margins (no. of patients, %)
 R0 51 (83)
 R1 5 (8.2)
 R2 0 (0)
 Unknown 5 (8.2)
ypT-stage (no. of patients, %)
 ypT0 19 (31)
 ypT1 18 (30)
 ypT2 14 (23)
 ypT3 5 (8.2)
 ypT4 1 (1.6)
 yTis 1 (1.6)
 Unknown 3 (4.9)
ypN-stage (no. of patients, %)
 ypN0 44 (72)
 ypN1 6 (9.8)
 ypN2 9 (15)
 Unknown 2 (3.3)
Mediastinal down-staging N2 (total cN2 = 35)
(no. of patients, %)
 cN2 Path. proven → ypN1 or ypN0 23 (65.7)
 cN2 Not path. proven → ypN1 or ypN0 4 (11.4)
 cN2 Path. proven → ypN2 6 (17.1)
 cN2 Not path. proven → ypN2 2 (5.7)
Post-resection 90-day mortality
(no. of patients, %) 3 (4.9)